Hooman Mirzakhani1, Vincent J Carey1, Robert Zeiger2, Leonard B Bacharier3, George T O'Connor4, Michael X Schatz2, Nancy Laranjo1, Scott T Weiss1,5, Augusto A Litonjua6. 1. Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 2. Department of Allergy and Research and Evaluation, Kaiser Permanente Southern California Region, San Diego and Pasadena, California. 3. Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University, St. Louis, Missouri. 4. Department of Medicine, Pulmonary Center, Boston Medical Center, Boston University, Boston, Massachusetts. 5. Partners Center for Personalized Medicine, Partners Health Care, Boston, Massachusetts. 6. Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Golisano Children's Hospital at Strong, University of Rochester Medical Center, Rochester, New York.
Abstract
BACKGROUND: While familial clustering of asthma is known, few studies have reported on the relative roles of paternal and maternal asthma and the role of maternal asthma control in pregnancy on the risk for asthma in the child. OBJECTIVE: We aimed to investigate the relative roles of paternal asthma, maternal asthma, and maternal asthma control during pregnancy on the risk of asthma or recurrent wheeze in 3-year-old children and how prenatal and cord blood vitamin D status might affect this risk. METHODS: Data from 806 women, their partners (biologic fathers of the infants), and their children participated in the Vitamin D Antenatal Asthma Reduction Trail (VDAART, clinicaltrials.gov identification number NCT00920621) were used for this cohort analysis. The parental report of physician-diagnosed asthma or recurrent wheeze in offspring was the main outcome. Weibull regression models for interval-censored event times were used to estimate the main variables of interests and additional covariates on the outcome. RESULTS: The highest risk was observed among children with both parents being asthmatic relative to non-asthmatic parents (aHR = 2.30, 95% CI: 1.35-3.84), and less so if only the mother was asthmatic (aHR = 1.70, 95% CI: 1.17-2.40). In the subset of children born to asthmatic mothers, the risk for asthma was higher in those who were born to mothers whose asthma was uncontrolled (aHR = 1.60, 95% CI: 1.02-2.54). Children whose mothers had sufficient vitamin D status (25Hydroxyvitamin D ≥ 30 ng/mL) at early and late pregnancy and had cord blood vitamin D sufficiency demonstrated a lower risk of asthma/recurrent wheeze than children who had insufficient cord blood vitamin D status at birth (aHR = 0.47, 95% CI: 0.27-0.83). CONCLUSION AND CLINICAL RELEVANCE: Careful attention to maternal asthma control, monitoring vitamin D status, and correcting insufficiency at early pregnancy and maintaining the sufficiency status throughout pregnancy have potential preventive roles in offspring asthma or recurrent wheeze.
BACKGROUND: While familial clustering of asthma is known, few studies have reported on the relative roles of paternal and maternal asthma and the role of maternal asthma control in pregnancy on the risk for asthma in the child. OBJECTIVE: We aimed to investigate the relative roles of paternal asthma, maternal asthma, and maternal asthma control during pregnancy on the risk of asthma or recurrent wheeze in 3-year-old children and how prenatal and cord blood vitamin D status might affect this risk. METHODS: Data from 806 women, their partners (biologic fathers of the infants), and their children participated in the Vitamin D Antenatal Asthma Reduction Trail (VDAART, clinicaltrials.gov identification number NCT00920621) were used for this cohort analysis. The parental report of physician-diagnosed asthma or recurrent wheeze in offspring was the main outcome. Weibull regression models for interval-censored event times were used to estimate the main variables of interests and additional covariates on the outcome. RESULTS: The highest risk was observed among children with both parents being asthmatic relative to non-asthmatic parents (aHR = 2.30, 95% CI: 1.35-3.84), and less so if only the mother was asthmatic (aHR = 1.70, 95% CI: 1.17-2.40). In the subset of children born to asthmatic mothers, the risk for asthma was higher in those who were born to mothers whose asthma was uncontrolled (aHR = 1.60, 95% CI: 1.02-2.54). Children whose mothers had sufficient vitamin D status (25Hydroxyvitamin D ≥ 30 ng/mL) at early and late pregnancy and had cord blood vitamin D sufficiency demonstrated a lower risk of asthma/recurrent wheeze than children who had insufficient cord bloodvitamin D status at birth (aHR = 0.47, 95% CI: 0.27-0.83). CONCLUSION AND CLINICAL RELEVANCE: Careful attention to maternal asthma control, monitoring vitamin D status, and correcting insufficiency at early pregnancy and maintaining the sufficiency status throughout pregnancy have potential preventive roles in offspring asthma or recurrent wheeze.
Authors: Michael B Bracken; Kathleen Belanger; William O Cookson; Elizabeth Triche; David C Christiani; Brian P Leaderer Journal: Epidemiol Rev Date: 2002 Impact factor: 6.222
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Debra A Stern; Stefano Guerra; Marilyn Halonen; Anne L Wright; Fernando D Martinez Journal: J Allergy Clin Immunol Date: 2007-08-08 Impact factor: 10.793
Authors: M K Rochat; M J Ege; D Plabst; J Steinle; S Bitter; C Braun-Fahrländer; J-C Dalphin; J Riedler; M Roponen; M-R Hirvonen; G Büchele; H Renz; R Lauener; S Krauss-Etschmann; E von Mutius Journal: Clin Exp Allergy Date: 2009-12-16 Impact factor: 5.018
Authors: Yohan Bossé; Mathieu Lemire; Audrey H Poon; Denise Daley; Jian-Qing He; Andrew Sandford; John H White; Alan L James; Arthur William Musk; Lyle J Palmer; Benjamin A Raby; Scott T Weiss; Anita L Kozyrskyj; Allan Becker; Thomas J Hudson; Catherine Laprise Journal: Respir Res Date: 2009-10-24
Authors: Anne K Bozack; Elena Colicino; Rodosthenis S Rodosthenous; Tessa R Bloomquist; Andrea A Baccarelli; Robert O Wright; Rosalind J Wright; Alison G Lee Journal: Epigenomics Date: 2022-05-31 Impact factor: 4.357
Authors: Mengdi Lu; Augusto A Litonjua; George T O'Connor; Robert S Zeiger; Leonard Bacharier; Michael Schatz; Vincent J Carey; Scott T Weiss; Hooman Mirzakhani Journal: J Allergy Clin Immunol Date: 2020-08-19 Impact factor: 10.793
Authors: Kathryn E McCauley; Elze Rackaityte; Brandon LaMere; Douglas W Fadrosh; Kei E Fujimura; Ariane R Panzer; Din L Lin; Kole V Lynch; Joanna Halkias; Ventura F Mendoza; Trevor D Burt; Casper Bendixsen; Kathrine Barnes; Haejin Kim; Kyra Jones; Dennis R Ownby; Christine C Johnson; Christine M Seroogy; James E Gern; Homer A Boushey; Susan V Lynch Journal: Cell Rep Med Date: 2022-08-06
Authors: Leah Cuthbertson; Stephen W C Oo; Michael J Cox; Siew-Kim Khoo; Des W Cox; Glenys Chidlow; Kimberley Franks; Franciska Prastanti; Meredith L Borland; James E Gern; David W Smith; Joelene A Bizzintino; Ingrid A Laing; Peter N Le Souëf; Miriam F Moffatt; William O C Cookson Journal: PLoS One Date: 2019-10-17 Impact factor: 3.240